Decreased Abundance of Genus Slackia in Individuals With Obesity and Colorectal Adenoma
Authors:
Open Access
- 11 March 2024
- journal article
- research article
- Published by Elsevier in Gastro Hep Advances
- Vol. 3 (5) , 573-582
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 42 references indexed in Scilit:
- The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2022
- Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patientsnpj Biofilms and Microbiomes, 2021
- Characteristics of the gut microbiome profile in obese patients with colorectal cancerJGH Open, 2021
- Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancerNature Medicine, 2019
- Increased levels of serum glucose-dependent insulinotropic polypeptide as a novel risk factor for human colorectal adenomaMetabolism, 2011
- Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTSArchives of Microbiology, 2010
- Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndromeDiabetes Research and Clinical Practice, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentrationThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Antioxidant Efficacy of Phytoestrogens in Chemical and Biological Model SystemsArchives of Biochemistry and Biophysics, 1998